Used as a key intermediate in the synthesis of antipsychotic medications, such as haloperidol, and other central nervous system (CNS) agents. The compound's structure, with 4-chloro and 4'-fluoro substituted phenyl rings on a butyrophenone backbone, enables the incorporation of halogenated aromatic groups that improve metabolic stability and receptor binding in target molecules. It is widely employed in pharmaceutical research for developing neuroleptic drugs and preparing structural analogs for structure-activity relationship (SAR) studies.